In addition to these alternative metabolic routes, specific glutamine transporters such as SLC1A5 (ASCT2) and SLC7A5 (LAT1) play crucial roles in glutamine uptake and metabolic reprogramming in both cancer and sepsis [48]. This evidence concerns the gene SLC1A5 and cancer.